London-based Verdiva Bio launches with €398.4M to problem Ozempic’s reign in weight problems therapy
On Thursday, London-based Verdiva Bio Restricted, a clinical-stage biopharmaceutical firm, introduced its launch to deal with creating progressive therapies for ...